ATLANTA, April 29 /PRNewswire/ -- Xoft, Inc., developer of the Axxent® Electronic Brachytherapy, eBxâ„¢ System, which delivers non-radioactive, electronic radiation therapy directly to cancer sites with ...
Multi-center research presented at ASTRO 2018 shows IORT with the Xoft System is safe with low recurrence and low morbidity in the treatment of breast cancer Company marks 20 years of innovations in ...
iCAD Reports Growing Adoption of Its Xoft Electronic Brachytherapy System by Leading U.S. Regional H
iCAD Reports Growing Adoption of Its Xoft Electronic Brachytherapy System by Leading U.S. Regional Hospitals "The continued adoption of the Xoft System emphasizes that it is increasingly being used ...
NASHUA, N.H., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announced today that Elekta ...
NASHUA, N.H., Oct. 23, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company ...
NASHUA, N.H. and VIENNA, Austria, May 05, 2017 (GLOBE NEWSWIRE) -- (Booth #4330) - iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy ...
SUNNYVALE, Calif., March 17 /PRNewswire/ -- Xoft, Inc., today announced that it has received expanded clearance from the U.S. Food & Drug Administration (FDA) for the Axxent(R) Electronic ...
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the ...
Xoft Secures $25 Million in Additional Funding for Award-Winning Electronic Brachytherapy Technology
SUNNYVALE, Calif., Aug. 11 Xoft, Inc., developer ofElectronic Brachytherapy (eBx), a proprietary cancer treatment platform,announced today that the company has closed its Series E preferred ...
iCAD Expands Global Distribution of the Xoft Electronic Brachytherapy System with Agreements in Asia
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) , a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the ...
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) , a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the ...
<0> For iCADKevin Burns, 937-431-7967orFor iCAD investor inquiriesLHAAnne Marie Fields, 212-838-3777orFor iCAD media inquiriesSchwartz MSLRachel Gross, 781-684-0770 </0> iCAD, Inc. (Nasdaq: ICAD), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results